Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline vs Levodopa in Restless Legs Syndrome
NCT00625547Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of cabergoline in restless legs syndrome (RLS), sponsored by Pfizer. Started Jan 2003; status: completed.
02
Drugs
cabergoline
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00625547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625547.